Drug Type Fusion protein |
Synonyms next-generation TriKE (head ) |
Target |
Action modulators, agonists |
Mechanism EpCAM modulators(Epithelial cell adhesion molecule modulators), FcRIII agonists(Low affinity immunoglobulin gamma Fc region receptor III agonists), IL-15Rα agonists(Interleukin-15 receptor subunit alpha agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Preclinical | United States | - |